课题基金 / 基金详情

项目摘要

项目成果

David A Tuveson的其他基金

相似基金

相关文献

中文摘要
翻译
发展基金--项目摘要/摘要 冷泉港实验室(CSHL)癌症中心以富有创造力和活力的员工为标志, 创新和协作研究,并强调开发在 世界各地的癌症研究实验室。癌症中心发展基金提供了关键的种子资金 战略招聘6名新教师,通过12个试点促进协作和跨学科科学 项目,并通过八个技术开发项目的共享资源激励创新。使用 在执行委员会和高级领导的支持下,癌症中心主任利用了这些资金 落实中心的战略举措。当与大量的机构支持和 慈善基金,这些发展基金产生了巨大的投资回报,其中包括48 已发表的论文和预印本,以及另外9篇正在编写或正在审查的论文。此外,资金 因为新的调查人员得出的数据支持成功申请超过570万美元的同业- 审查了外部资金,过去五年共成功资助了25笔外部赠款。作为一名 整个发展基金是一个极其宝贵的支持来源,使CSHL癌症中心能够 对癌症的生物学机制做出根本性的发现,并开发出独特的 癌症的诊断、治疗和预防方法。
英文摘要
DEVELOPMENTAL FUNDS – PROJECT SUMMARY/ABSTRACT The Cold Spring Harbor Laboratory (CSHL) Cancer Center is marked by creative and energetic faculty, innovative and collaborative research, and an emphasis on developing technologies that are used broadly in cancer research labs around the world. Cancer Center Developmental Funds have provided critical seed funding to strategically recruit six new faculty, stimulated collaboration and interdisciplinary science through twelve pilot projects, and spurred innovation through the Shared Resources in eight technology-development projects. With the support of the Executive Committee and Senior Leadership, the Cancer Center Director utilized these funds to implement the Center’s strategic initiatives. When paired with substantial Institutional support and philanthropic funding, these Developmental Funds resulted in significant returns on investment, including 48 published papers and preprints and nine additional papers in preparation or under review. In addition, funding for new investigators led to data that supported the successful application for more than $5.7 million in peer- reviewed external funding and a total of 25 successfully funded external grants over the last five years. As a whole, Developmental Funds are an extremely valuable source of support that enables the CSHL Cancer Center to make fundamental discoveries about the biological mechanisms underlying cancer and to develop unique approaches towards the diagnosis, treatment, and prevention of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10675741
  • 项目类别:
  • 资助金额:
    $78.02万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10299050
  • 项目类别:
  • 资助金额:
    $81.89万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10467049
  • 项目类别:
  • 资助金额:
    $78.0万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
  • 批准号:
    10056198
  • 项目类别:
  • 资助金额:
    $61.57万
  • 财政年份:
    2016
  • 负责人:
    David A Tuveson
  • 依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    贺萍
  • 依托单位: